Global Direct-to-Consumer (DTC) Genetic Testing Market, By Service (Diagnostic Screening, Prenatal, New-born Screening, Pre-Implantation Diagnosis and Relationship Testing), Test Type (Carrier Testing, Predictive Testing, Ancestry and Relationship Testing, Nutrigenomics Testing and Others), Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips and Whole Genome Sequencing (WGS)), Product Type (Ancestry, Health and Wellness and Entertainment), Business Model (Genome Data Bank Material Model, Individual Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model and Restricted Trait Tests Model), End User (Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centres, Home Care, Cosmetics and Others), Sales Channel (Online Sales, OTC Sales and Doctor's Office), and Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Direct-to-Consumer (DTC) Genetic Testing Market
The direct-to-consumer (DTC) genetic testing market is expected to witness market growth at a rate of 12.15% in the forecast period of 2021 to 2028. Data Bridge Market Research report on direct-to-consumer (DTC) genetic testing market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the incidences of genetic disorders globally is escalating the growth of direct-to-consumer (DTC) genetic testing market.
Direct-To-Consumer (DTC) Testing can also be known as direct access testing, which allows the customers to order laboratory tests directly from a laboratory without necessarily having to work with their healthcare provider.
Major factors that are expected to boost the growth of the direct-to-consumer (DTC) genetic testing market in the forecast period are the rise in the public alertness. Furthermore, the increase in the income level in the advancing countries is further anticipated to propel the growth of the direct-to-consumer (DTC) genetic testing market. On the other hand, the rise in the cost of DTC genetic testing is further projected to impede the growth of the direct-to-consumer (DTC) genetic testing market in the timeline period.
In addition, the rise in the need for service personalization will further provide potential opportunities for the growth of the direct-to-consumer (DTC) genetic testing market in the coming years. However, the shortcomings in the DTC testing kits might further challenge the growth of the direct-to-consumer (DTC) genetic testing market in the near future.
This direct-to-consumer (DTC) genetic testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on direct-to-consumer (DTC) genetic testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Direct-to-Consumer (DTC) Genetic Testing Market Scope and Market Size
The direct-to-consumer (DTC) genetic testing market is segmented on the basis of service, test type, technology, product type, business model, end user and sales channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of service, the direct-to-consumer (DTC) genetic testing market is segmented into diagnostic screening, prenatal, new-born screening, pre-implantation diagnosis and relationship testing.
- On the basis of test type, the direct-to-consumer (DTC) genetic testing market is segmented into carrier testing, predictive testing, ancestry and relationship testing and nutrigenomics testing and others.
- On the basis of technology, the direct-to-consumer (DTC) genetic testing market is segmented into targeted analysis, single nucleotide polymorphism (SNP) chips and whole genome sequencing (WGS).
- On the basis of product type, the direct-to-consumer (DTC) genetic testing market is segmented into ancestry, health and wellness, entertainment.
- On the basis of business model, genome data bank material model, individual health planning model, comprehensive genome tests model, medical precision tests model, restricted trait tests model.
- On the basis of end user, the direct-to-consumer (DTC) genetic testing market is segmented into laboratories, blood banks, nursing homes, hospitals, imaging centres, home care, cosmetics, others.
- On the basis of sales channel, the direct-to-consumer (DTC) genetic testing market is segmented into online sales, OTC sales and doctor's office.
Direct-to-Consumer (DTC) Genetic Testing Market Country Level Analysis
The direct-to-consumer (DTC) genetic testing market is analysed and market size insights and trends are provided by country, service, test type, technology, product type, business model, end user and sales channel as referenced above.
The countries covered in the direct-to-consumer (DTC) genetic testing market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the direct-to-consumer (DTC) genetic testing market due to the shift in the outlook of consumers towards genetic testing. Furthermore, the rise in the expenditure will further boost the growth of the direct-to-consumer (DTC) genetic testing market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the direct-to-consumer (DTC) genetic testing market due to the rise in the health care awareness. Moreover, the increase in the disposable income is further anticipated to propel the growth of the direct-to-consumer (DTC) genetic testing market in the region in the coming years.
The country section of the direct-to-consumer (DTC) genetic testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The direct-to-consumer (DTC) genetic testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for direct-to-consumer (DTC) genetic testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the direct-to-consumer (DTC) genetic testing market. The data is available for historic period 2010-2019.
Competitive Landscape and Direct-to-Consumer (DTC) Genetic Testing Market Share Analysis
The direct-to-consumer (DTC) genetic testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to direct-to-consumer (DTC) genetic testing market.
The major players covered in the direct-to-consumer (DTC) genetic testing market report are EasyDNA, Ancestry, 23andMe, Inc., Colour Genomics, Inc., Genesis HealthCare, Full Genomes Corporation, Inc., Helix OpCo LLC, IDENTIGENE, LLC, Living DNA Ltd, Mapmygenome, Pathway Genomics, Gene by Gene, Ltd., MyHeritage Ltd., 10X Genomics, Dante Labs, Inc., 24Genetics, LabCorp, Myriad Genetics, Inc., Quest Diagnostics Incorporated and Abacus Diagnostica Oy among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-